The forecast for Germany's import of vaccines for human use indicates a steady growth from 2024 to 2028, starting at $1.2495 billion and reaching $1.3134 billion by 2028. As we stand in 2024, these figures show an upward trend with year-on-year growth rates ranging between 1.3% and 1.5% annually over the forecast period. Considering the absence of 2023 values, the compound annual growth rate (CAGR) over the five-year period reflects a modest, yet consistent increase.
Looking forward, it's important to watch for potential shifts in global supply chains, new technological advancements in vaccine production, and changes in health policy within Europe that could impact these forecasts. Additionally, vaccine demand driven by emerging health concerns or pandemics could significantly alter import values.
